Unbiased Analysis of Today's Healthcare Issues
According to a paper this month in Value in Health from Anupam Bapu Jena, Julia Thornton Snider, Oliver Diaz Espinosa, Andy Ingram, Yuri Sanchez Gonzalez and Darius Lakdawalla, the answer is ‘yes’. The authors look at how curing chronic hepatitis C affects the likelihood of getting a liver, lung, heart, or kidney transplant for individuals…
Do you want to cure cancer? Diabetes? HIV? Imagine if there was a single pill for each of these diseases that one could take to cure the diseases. That would be a clear clinical advance, it would save lives, and also save money form reducing the cost of treating these disease. Can we expect to…
David Augus and and Dana Goldman weigh in on Novartis’ decision to price their new chimeric antigen receptor T-cell (CAR-T) therapy known as Kymriah (tisagenlecleucel). The treatment represents ground-breaking technology, but is priced at $475,000 per treatment. But the authors note that there is something else novel about this technology: There was another announcement from…